Genetics and Healthcare Initiative

Medicine & Life Sciences

1. Major Depressive Disorder 100%
2. Genome 76%
3. Scotland 59%
4. Depression 58%
5. Meta-Analysis 54%
6. Genome-Wide Association Study 52%
7. Genetic Loci 51%
8. Genes 50%
9. Psychological Resilience 50%
10. Neurobiology 45%
11. Population 45%
12. Family Health 42%
13. Hyperlipoproteinemia Type II 39%
14. Genetic Testing 35%
15. Gene Regulatory Networks 34%
16. Single Nucleotide Polymorphism 31%
17. Reward 30%
18. High-Throughput Nucleotide Sequencing 30%
19. Alcohol Drinking 29%
20. Cognition 27%
21. Brain 26%
22. Young Adult 25%
23. China 25%
24. Nucleotides 25%
25. Smoking 25%
26. Emotions 25%
27. Alzheimer Disease 24%
28. Exome 24%
29. Lipids 23%
30. Cholesterol 23%
31. Learning 23%
32. Exercise 20%
33. Health 20%
34. Mental Disorders 19%
35. Linear Models 18%
36. Sample Size 18%
37. Anhedonia 15%
38. Twin Studies 15%
39. HDL Cholesterol 14%
40. Mutation 13%
41. Gene Expression 12%
42. Loss of Function Mutation 12%
43. Memory 12%
44. LDL Cholesterol 11%
45. Psychology Reinforcement 11%
46. Aptitude 11%
47. Brain Diseases 10%
48. Intellectual Disability 10%
49. Uniparental Disomy 9%
50. Pedigree 8%
51. Statistics 8%
52. Alleles 8%
53. Genomics 8%
54. Smoking Cessation 8%
55. Alcohols 8%
56. Equipment and Supplies 7%
57. Multifactorial Inheritance 7%
58. Chromosomes, Human, Pair 1 7%
59. low density lipoprotein triglyceride 7%
60. Age of Onset 7%
61. Genotype 7%
62. Odorant Receptors 7%
63. Siblings 7%
64. Primary Health Care 7%
65. Health Resources 7%
66. Cognitive Dysfunction 7%
67. Ventral Striatum 7%
68. Principal Component Analysis 6%
69. Catalogs 6%
70. Direction compound 6%
71. Lipid Metabolism 6%
72. Hispanic Americans 6%
73. Essential Genes 6%
74. Haplotypes 6%
75. Synaptic Transmission 6%
76. Nucleus Accumbens 5%
77. Substantia Nigra 5%
78. Smoking Prevention 5%
79. Population Genetics 5%
80. Gyrus Cinguli 5%
81. Microfluidics 5%
82. Psychopathology 5%
83. Thalamus 5%
84. Self Concept 5%
85. Life Style 5%
86. Corpus Striatum 5%
87. Reproduction 5%
88. Multiplex Polymerase Chain Reaction 5%
89. Frontal Lobe 5%